| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |